2021 ISAR Global Research Project
Effectiveness of biologics (by classes) in patients with different combination of T2 biomarkers (IGNITE)
To describe the prevalence and overlap of elevated T2 biomarkers, related to specific T2 pathways (eosinophils (IL5), FeNO (IL13), IgE (IL4)), and the relationship between the T2 marker profile and the outcome of biological treatment.
- Dr Celeste M. Porsbjerg
- Dr Trung N. Tran
ENCePP Approval:
ADEPT Approval: